Table 2.
Thyroid FNA Neoplastic Case Performance From the ASCP Non-GYN Assessment Program
| Target Diagnosis | A | B | C | D | E | Responses |
|---|---|---|---|---|---|---|
| Anaplastic carcinoma | 141 (86.5%) | 0 (0%) | 18 (11%) | 4 (2.5%) | Hürthle cell neoplasm | 163 |
| Hürthle cell neoplasm | 223 (83.5%) | 18 (6.75%) | 0 (0%) | 26 (9.75%) | Papillary carcinoma | 267 |
| Papillary carcinoma | 497 (83%) | 32 (5.5%) | 25 (4.25%) | 45 (7.25%) | Medullary carcinoma | 599 |
| Medullary carcinoma | 177 (79%) | 16 (7%) | 14 (6%) | 18 (8.00%) | Follicular neoplasm | 225 |
| Follicular neoplasm | 185 (61%) | 67 (22%) | 0 (0%) | 52 (17%) | Papillary carcinoma | 304 |
| Totals | 1223 (78.50%) | 133 (8.5%) | 57 (3.75%) | 145(9.25%) | 1558 |